netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 15 of 15


Details
LDL Link Added : MHRA Drug Safety Update (Feb 2020): Lemtrada▼ (alemtuzumab): updated restrictions and strengthened monitoring requirements following review of serious cardiovascular and immune-mediated reactions : https://www.gov.uk/drug-safety-update/
06/07/2023 11:37:42
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (May 2019): Lemtrada (alemtuzumab) and serious cardiovascular and immune- mediated adverse reactions: new restrictions to use and strengthened monitoring requirements : https://www.gov.uk/drug-safety-update/lemtrada-al
06/07/2023 11:37:29
(rpaylor )
UPD sitematrix Changed from 0 to
27/07/2022 08:33:07
(LoweryM )
UPD FurtherInformation Changed from
27/07/2022 08:33:07
(LoweryM )
UPD Alemtuzumab FORMATTING
27/07/2022 08:33:07
(LoweryM )
UPD Alemtuzumab update
05/06/2018 09:12:06
(LoweryM )
UPD Alemtuzumab dhs
22/02/2018 08:54:22
(DavidS )
UPD Alemtuzumab updated
22/02/2018 08:54:01
(DavidS )
UPD Alemtuzumab b
01/02/2017 15:51:20
(DavidS )
UPD Alemtuzumab b
24/01/2017 13:13:58
(WhitehallJ )
LDL Link Added : NICE TA312: Alemtuzumab for relapsing‑remitting multiple sclerosis : https://www.nice.org.uk/guidance/ta312?UNLID=9391214302017124131150
24/01/2017 13:12:31
(WhitehallJ )
UPD Alemtuzumab b
24/01/2017 13:11:51
(WhitehallJ )
UPD Alemtuzumab b
24/01/2017 13:11:23
(WhitehallJ )
UPD Alemtuzumab b
24/01/2017 13:11:10
(WhitehallJ )
UPD Alemtuzumab (MabCampath®) build
28/11/2016 17:02:12
(DavidS )

 

 

netFormulary